Litcius/Paper detail

Whole-Genome Methylation Sequencing Reveals that COVID-19–induced Epigenetic Dysregulation Remains 1 Year after Hospital Discharge

Joseph Balnis, Andy Madrid, Kirk J. Hogan, Lisa A. Drake, Anish Adhikari, Rachel Vancavage, Harold A. Singer, Reid S. Alisch, Ariel Jaitovich

2023American Journal of Respiratory Cell and Molecular Biology22 citationsDOIOpen Access PDF

Abstract

growth and mobilization of wild-type and mutated cells, leading to the formation of hamartomas or benign tumors (Figure 1E).LAM cells in the lung and circulation can increase the production of CD44v6 regulators (OPN, HGF, SDF-1 or CXCL12).The production of these growth factors can be potentiated on the basis of the genotype of each patient.The fact that CD44v6 is a coreceptor of HGF supports a positive paracrine and autocrine feedback mechanism of action of the microenvironment by increasing the concentrations of HGF and increasing the splicing of CD44 to generate CD44v6 and potentiating LAM cell growth.Therefore, neoplastic LAM cells appear to interact with and require the cells of the microenvironment (e.g., macrophages, neutrophils) to form nodules or "microtumors.

Topics & Concepts

EpigeneticsCoronavirus disease 2019 (COVID-19)MethylationDNA methylationWhole genome sequencingBiologyGenomeGeneticsMedicineGeneDiseaseInternal medicineGene expressionInfectious disease (medical specialty)Epigenetics and DNA MethylationChildhood Cancer Survivors' Quality of LifePalliative Care and End-of-Life Issues